<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PSA Rising Prostate Cancer Blog &#187; Maha Hussain M.D</title>
	<atom:link href="http://www.psa-rising.com/blog/tag/maha-hussain-md/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.psa-rising.com/blog</link>
	<description></description>
	<lastBuildDate>Wed, 25 Nov 2009 18:36:49 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Second oncologist asks FDA to wait on Provenge</title>
		<link>http://www.psa-rising.com/blog/2007/04/second-oncologist-asks-fda-to-wait-on-provenge/</link>
		<comments>http://www.psa-rising.com/blog/2007/04/second-oncologist-asks-fda-to-wait-on-provenge/#comments</comments>
		<pubDate>Thu, 26 Apr 2007 17:31:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clinical trials]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Maha Hussain M.D]]></category>

		<guid isPermaLink="false">http://psa-rising.com/blog/index.php/2007/04/26/second-oncologist-asks-fda-to-wait-on-provenge/</guid>
		<description><![CDATA[Dr. Maha Hussain (left) is calling for an open access program for Dendreon&#8217;s Provenge prostate cancer vaccine (Sipuleucel-T) pending completion of an ongoing, 500 man clinical trial, She made this suggestion March 29 during the FDA Advisory Committee hearing after voting &#8220;No&#8221; on the vaccine&#8217;s efficacy.  She followed up with a letter to the [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2007/04/second-oncologist-asks-fda-to-wait-on-provenge/feed/</wfw:commentRss>
		<slash:comments>10</slash:comments>
		</item>
		<item>
		<title>A call for open access to Dendreon&#8217;s prostate cancer vaccine</title>
		<link>http://www.psa-rising.com/blog/2007/04/a-call-for-open-access-program-prostate-cancer-vaccine/</link>
		<comments>http://www.psa-rising.com/blog/2007/04/a-call-for-open-access-program-prostate-cancer-vaccine/#comments</comments>
		<pubDate>Thu, 26 Apr 2007 17:09:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clinical trials]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Maha Hussain M.D]]></category>

		<guid isPermaLink="false">http://psa-rising.com/blog/index.php/2007/04/26/a-call-for-open-access-program-prostate-cancer-vaccine/</guid>
		<description><![CDATA[Dr. Maha Hussain, an oncologist who was one of 4 out of 17 members of the FDA Advisory Committee to vote against accepting against the company&#8217;s claim to efficacy for Provenge (Sipuleucel-T) prostate cancer vaccine, is calling for an expanded access program to empower patients who want and need it to receive the drug while [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2007/04/a-call-for-open-access-program-prostate-cancer-vaccine/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
